IP Library Granted Patent US 7,148,330
Granted Patent B2
US 7,148,330 · App. 10/000,776 · Granted Dec 12, 2006

Binding compounds for IL-27

Assignee: Schering Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,148,330
App. No.
10/000,776
Granted
Dec 12, 2006
Kind
B2
Abstract

Purified genes encoding a cytokine or composite cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding these molecules are provided. Methods of using said reagents and diagnostic kits are also provided.

Claims (26)

1. An isolated antibody, or antigen-binding fragment thereof, that specifically binds to a polypeptide consisting of SEQ ID NO:2.

2. The antibody of claim 1 that is monoclonal.

3. The antibody of claim 1 that is a humanized or chimeric antibody.

4. The antibody or fragment of claim 1 , that is:

a) raised against a purified or recombinantly produced protein comprising SEQ ID NO:2;

b) Fab or F(ab)2;

c) a polyclonal antiserum;

d) detectably labeled;

e) sterile; or

f) in a buffered composition.

5. A kit comprising the antibody or fragment of claim 1 , and a compartment, wherein said antibody or fragment is contained within said compartment.

6. The kit of claim 5 wherein the antibody or fragment is detectably labeled.

7. The kit of claim 6 wherein the antibody or fragment is labeled with an enzyme, a fluorescent label, radioisotope or biotinylation.

8. An isolated antibody, or antigen-binding fragment thereof, that specifically binds to a polypeptide consisting of SEQ ID NO:6.

9. The antibody of claim 8 that is monoclonal.

10. The antibody of claim 8 that is a humanized or chimeric antibody.

11. The antibody or fragment of claim 8 , that is:

a) raised against a purified or recombinantly produced protein comprising SEQ ID NO:6;

b) Fab or F(ab)2;

c) a polyclonal antiserum;

d) detectably labeled;

e) sterile; or

f) in a buffered composition.

12. A kit comprising the antibody or fragment of claim 8 , and a compartment, wherein said antibody or fragment is contained within said compartment.

13. The kit of claim 12 wherein the antibody or fragment is detectably labeled.

14. The kit of claim 13 wherein the antibody or fragment is labeled with an enzyme, a fluorescent label, radioisotope or biotinylation.

Assignments (2)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2002
From: TIMANS, JACQUELINE C.; PFLANZ, STEFAN KARL-HEINZ; KASTELEIN, ROBERT A.; BAZAN, J. FERNANDO; RENNICK, DONNA; DE WAAL MALEFYT, RENE; CHEUNG, JEANNE
To: SCHERING CORPORATION
Reel/Frame 012741/0638 →
Continuity (5)
Continuation In Part 0979149700 · Feb 22, 2001
Continuation In Part 0962789700 · Jul 27, 2000
Provisional Application 6014776300 · Aug 6, 1999
Provisional Application 6014658100 · Jul 30, 1999
Related Publication 20020164609A1 · Nov 7, 2002